Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Sep 7;303(6802):531–532. doi: 10.1136/bmj.303.6802.531

Major orthopaedic surgery on the leg and thromboembolism.

J Parker-Williams, R Vickers
PMCID: PMC1670904  PMID: 1655134

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenkel I. J., Clancy M. J. Total hip replacement and antithrombotic prophylaxis. Br J Hosp Med. 1989 Oct;42(4):282–284. [PubMed] [Google Scholar]
  2. Fordyce M. J., Baker A. S., Staddon G. E. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ. 1991 Jul 27;303(6796):219–220. doi: 10.1136/bmj.303.6796.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Francis C. W., Marder V. J., Evarts C. M., Yaukoolbodi S. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. JAMA. 1983 Jan 21;249(3):374–378. doi: 10.1001/jama.249.3.374. [DOI] [PubMed] [Google Scholar]
  4. Haake D. A., Berkman S. A. Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis, and diagnosis. Clin Orthop Relat Res. 1989 May;(242):212–231. [PubMed] [Google Scholar]
  5. Harris W. H., Salzman E. W., Athanasoulis C., Waltman A. C., Baum S., DeSanctis R. W. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg Am. 1974 Dec;56(8):1552–1562. [PubMed] [Google Scholar]
  6. Kroon C., de Boer A., Kroon J. M., Schoemaker H. C., van den Meer F. J., Cohen A. F., Schoenmaker H. C. Influence of skinfold thickness on heparin absorption. Lancet. 1991 Apr 20;337(8747):945–946. doi: 10.1016/0140-6736(91)91573-d. [DOI] [PubMed] [Google Scholar]
  7. Lassen M. R., Borris L. C., Christiansen H. M., Boll K. L., Eiskjaer S. P., Nielsen B. W., Schøtt P., Olsen A. D., Rodenberg J. C., Lucht U. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand. 1991 Feb;62(1):33–38. doi: 10.3109/17453679108993088. [DOI] [PubMed] [Google Scholar]
  8. Lassen M. R., Borris L. C. Mobilisation after hip surgery and efficacy of thromboprophylaxis. Lancet. 1991 Mar 9;337(8741):618–618. doi: 10.1016/0140-6736(91)91686-o. [DOI] [PubMed] [Google Scholar]
  9. Laverick M. D., Croal S. A., Mollan R. A. Orthopaedic surgeons and thromboprophylaxis. BMJ. 1991 Sep 7;303(6802):549–550. doi: 10.1136/bmj.303.6802.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leyvraz P. F., Bachmann F., Hoek J., Büller H. R., Postel M., Samama M., Vandenbroek M. D. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ. 1991 Sep 7;303(6802):543–548. doi: 10.1136/bmj.303.6802.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leyvraz P. F., Richard J., Bachmann F., Van Melle G., Treyvaud J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 1983 Oct 20;309(16):954–958. doi: 10.1056/NEJM198310203091605. [DOI] [PubMed] [Google Scholar]
  12. Moskovitz P. A., Ellenberg S. S., Feffer H. L., Kenmore P. I., Neviaser R. J., Rubin B. E., Varma V. M. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg Am. 1978 Dec;60(8):1065–1070. [PubMed] [Google Scholar]
  13. Mätzsch T., Bergqvist D., Fredin H., Hedner U. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement. Acta Chir Scand. 1990 Jun-Jul;156(6-7):445–450. [PubMed] [Google Scholar]
  14. Planes A., Vochelle N., Mazas F., Mansat C., Zucman J., Landais A., Pascariello J. C., Weill D., Butel J. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost. 1988 Dec 22;60(3):407–410. [PubMed] [Google Scholar]
  15. Salzman E. W. Low-molecular-weight heparin: is small beautiful? N Engl J Med. 1986 Oct 9;315(15):957–959. doi: 10.1056/NEJM198610093151509. [DOI] [PubMed] [Google Scholar]
  16. Thomas D. P. Current status of low molecular weight heparin. Thromb Haemost. 1986 Dec 15;56(3):241–242. [PubMed] [Google Scholar]
  17. Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Hull R. D., Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986 Oct 9;315(15):925–929. doi: 10.1056/NEJM198610093151503. [DOI] [PubMed] [Google Scholar]
  18. Vitoux J. F., Aiach M., Roncato M., Fiessinger J. N. Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight? Thromb Haemost. 1988 Feb 25;59(1):120–120. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES